CN1065762C - Medical capsule for regulating insulin and reducing blood and/or uric sugar - Google Patents
Medical capsule for regulating insulin and reducing blood and/or uric sugar Download PDFInfo
- Publication number
- CN1065762C CN1065762C CN98113999A CN98113999A CN1065762C CN 1065762 C CN1065762 C CN 1065762C CN 98113999 A CN98113999 A CN 98113999A CN 98113999 A CN98113999 A CN 98113999A CN 1065762 C CN1065762 C CN 1065762C
- Authority
- CN
- China
- Prior art keywords
- capsule
- reducing blood
- diabetes
- medicine
- sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a medical capsule for regulating the insulin and reducing blood and/or uric sugar, which is Chinese medicine for treating diabetes. The present invention has the weight proportioning: 20 to 30% of common yan rhizome, 15 to 10% of keel, 15 to 10% of oyster shell, 10 to 50% of pilose asiabell root, 8 to 3% of dwarf lilyturf tuber, 8 to 3% of pollen, 8 to 3% of milkvetch root, and 16 to 25% of dodder seed. The medicine has 'causal treatment' efficiency on the diabetes; the pancreas function can be regulated and increased; the pancreas can normally secrete insulin; the balance of various nutrition ingredients in the body is maintained, and the present invention has obvious therapeutic effects on the diabetes.
Description
The present invention is a kind of Chinese medicine for the treatment of diabetes, medical capsule for regulating insulin and reducing blood and/or uric sugar.
The medicine of existing at present treatment diabetes is directly the intravital sugar part of people to be reduced or suppressed to absorb mostly, and replenishes personal required insulin.The function of these medicines and treatment mechanism are controlling " mark ", can not effect a permanent cure, and patient must take medicine for a long time, just can keep the balance of nutrition in the person, alleviates slight illness.
The objective of the invention is to propose the diabetes Chinese medicine medical capsule for regulating insulin and reducing blood and/or uric sugar of a kind of controlling " basis ".According to the reason of onset diabetes is the pancreatic function imbalance, normal excreting insulin, and cause intravital sugar can not be decomposed into the required various nutrient substance of the person, thus cause that blood glucose, glucose in urine raise, the formation diabetes.The medical capsule for regulating insulin and reducing blood and/or uric sugar that the present invention proposes is the pancreatic function that improves the diabetes patient to adjust, and makes the normal excreting insulin of pancreas, keeps various nutrition balances in the body.
Major technique content of the present invention is, the formulation ratio of this medical capsule for regulating insulin and reducing blood and/or uric sugar is: Rhizoma Dioscoreae 20-30%, Os Draconis 15-10%, Concha Ostreae 15-10%, Radix Codonopsis 10-5%, Radix Ophiopogonis 8-3%, pollen 8-3%, Radix Astragali 8-3%, Semen Cuscutae 16-25%, its proportioning is weight proportion.
Preparation technology is, earlier every medicine is cleaned decontamination respectively, after solely place drying in oven to make it moisture every prescription less than 5%, after be ground into 80 purpose powder, after with every medicine by its weight proportion weighing, place mixer to mix, stir, it is standby in the non-toxic plastic bag to pack into, medicated powder is placed insert the capsule machine and carry out fill by operating provision and become capsule, is finished product through checking every 0.3 gram that weighs.
Technique effect of the present invention is, because having, the Rhizoma Dioscoreae in this medical capsule for regulating insulin and reducing blood and/or uric sugar transfers the function of pancreas excreting insulinization sugar for supporting, Os Draconis, Concha Ostreae have nourishing YIN for suppressing the hyperactive YANG and play equilibrated function, Radix Codonopsis has the recovery of promotion pancreatic function, Radix Ophiopogonis, pollen have hypoglycemic function, the Radix Astragali has the invigorating the spleen and replenishing QI function of quenching one's thirst, Semen Cuscutae helps kidney and keeps fit to act on, therefore organic cooperation of these several medicines can be reconciled the pancreatic function that recovers the diabetes patient, make its normal excreting insulin, change sugar for supporting, diabetes are had the effect of controlling " basis ", therapeutic effect is remarkable.General light moderate diabetics is taken 3 courses of treatment and is cured substantially, and be 90 days a course of treatment, take every day three times, one time six.Senile diabetes can reach discontinuity takes medicine, and is adjustable multiple if any recurring 1 week of taking medicine continuously.General young and middle-aged patient 1-2 recovers normal a course of treatment substantially.Use therapeutic effect good through Affiliated Hospital of Harbin Medical University to 30 diabetes patients.
The realization embodiments of the invention are: with Rhizoma Dioscoreae 20 gram, Os Draconis 15 grams, Concha Ostreae 15 grams, Radix Codonopsis 10 grams, Radix Ophiopogonis 8 gram, pollen 8 grams, the Radix Astragali 8 grams, Semen Cuscutae 16 grams, can be made into 100 gram regulating insulin and reducing blood and/or uric sugar medicated powder by above-mentioned process, can adorn 333 capsules by every 0.3 gram.
Claims (2)
1. Chinese medicine medical capsule for regulating insulin and reducing blood and/or uric sugar for the treatment of diabetes, it is characterized in that this capsule is made up of following component: Rhizoma Dioscoreae 20-30%, Os Draconis 15-10%, Concha Ostreae 15-10%, Radix Codonopsis 10-5%, Radix Ophiopogonis 8-3%, pollen 8-3%, Radix Astragali 8-3%, Semen Cuscutae 16-25%, its proportioning is weight ratio.
2. the production technology of the medical capsule for regulating insulin and reducing blood and/or uric sugar of claim 1, it is characterized in that earlier each medicine being cleaned decontamination respectively, each prescription of back solely places drying in oven to make it moisture less than 5%, after be ground into 80 order powder, then with every medicine by the proportioning weighing of its weight, place mixer to mix, stir, it is standby in the non-toxic plastic bag to pack into, medicated powder is placed insert the capsule machine and carry out fill by operating provision and become capsule, is finished product through checking every 0.3 gram that weighs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98113999A CN1065762C (en) | 1998-05-15 | 1998-05-15 | Medical capsule for regulating insulin and reducing blood and/or uric sugar |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98113999A CN1065762C (en) | 1998-05-15 | 1998-05-15 | Medical capsule for regulating insulin and reducing blood and/or uric sugar |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1238200A CN1238200A (en) | 1999-12-15 |
| CN1065762C true CN1065762C (en) | 2001-05-16 |
Family
ID=5223685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98113999A Expired - Fee Related CN1065762C (en) | 1998-05-15 | 1998-05-15 | Medical capsule for regulating insulin and reducing blood and/or uric sugar |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1065762C (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1102782A (en) * | 1992-12-22 | 1995-05-24 | 何振山 | Thirst-quenching infused medicine |
| CN1106271A (en) * | 1994-02-01 | 1995-08-09 | 张树成 | Method for prepn. of medicinal introducing bag for treating diabetes mellitus |
| CN1106413A (en) * | 1993-06-24 | 1995-08-09 | 戈尔德施米特股份公司 | Silane with hydrophilic group and preparation and application of same |
-
1998
- 1998-05-15 CN CN98113999A patent/CN1065762C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1102782A (en) * | 1992-12-22 | 1995-05-24 | 何振山 | Thirst-quenching infused medicine |
| CN1106413A (en) * | 1993-06-24 | 1995-08-09 | 戈尔德施米特股份公司 | Silane with hydrophilic group and preparation and application of same |
| CN1106271A (en) * | 1994-02-01 | 1995-08-09 | 张树成 | Method for prepn. of medicinal introducing bag for treating diabetes mellitus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1238200A (en) | 1999-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101690789B (en) | Chinese medicinal preparation for treating diabetes | |
| CN101062356A (en) | Chinese traditional medicine for treating children's enuresis | |
| CN1065762C (en) | Medical capsule for regulating insulin and reducing blood and/or uric sugar | |
| CN101168026A (en) | Traditional Chinese medicine for treating alcohol dependence disease | |
| CN1583154A (en) | Oral liquid and capsules of Chinese medicine for diabete by supplementing Qi and nourishing Yin and promotnig production of body fluid and quenching thirst | |
| CN1069203C (en) | Drug for curing diabetes | |
| CN101062351A (en) | Kidney-warming and yang-strengthening pill | |
| CN1066602A (en) | The compound method of hypoglycemic compound capsule | |
| CN101843843A (en) | Chinese medicament for treating diabetes | |
| CN1192789C (en) | 'Shenhuaxiaokecha' tea and preparing method thereof | |
| CN106729304B (en) | A kind of Chinese medicine for mitigating fasting or side reaction of dieting and preparation method thereof | |
| CN100566740C (en) | A kind of Chinese herb medicine of preventing and treating myopia | |
| CN1263488C (en) | Capsule of dual gen-sengs and preparing technique | |
| CN100455317C (en) | Medicament for treating type 2 diabetes | |
| CN1279955C (en) | Medicine tea for curing diabetes | |
| CN110538288A (en) | Intelligent system plaster for conditioning physique and preventing and treating diseases and preparation method thereof | |
| CN1097322A (en) | Oral liquid for decreasing blood sugar and compound method thereof | |
| CN106620251A (en) | Tea bag for relieving hyperglycemia | |
| CN1034672A (en) | The prescription of integrated pulse liquor and technological process | |
| CN1380070A (en) | Chinese medicine for curing diabetes | |
| CN1306830A (en) | Medicine for treating type II diabetes | |
| CN1327826A (en) | Hypoglycemic capsule | |
| CN1383848A (en) | Specific medicine for treating diabetes | |
| CN1243718A (en) | Chinese medicine for treating insulin-independent diabetes with special effect | |
| CN1113443A (en) | Xiaokekang bath powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |